Metser, U.; Kulanthaivelu, R.; Duder, J.; Hinzpeter, R.; Singh, S.; Wong, R.; Myrehaug, S.; Gray, D.; Veit-Haibach, P.; Singnurkar, A.;
et al. 68Ga-DOTATATE PET/CT in the Initial Staging of Well-Differentiated Gastroenteropancreatic and Non-Gastroenteropancreatic Neuroendocrine Tumors: Results of a Prospective Registry. Cancers 2025, 17, 434.
https://doi.org/10.3390/cancers17030434
AMA Style
Metser U, Kulanthaivelu R, Duder J, Hinzpeter R, Singh S, Wong R, Myrehaug S, Gray D, Veit-Haibach P, Singnurkar A,
et al. 68Ga-DOTATATE PET/CT in the Initial Staging of Well-Differentiated Gastroenteropancreatic and Non-Gastroenteropancreatic Neuroendocrine Tumors: Results of a Prospective Registry. Cancers. 2025; 17(3):434.
https://doi.org/10.3390/cancers17030434
Chicago/Turabian Style
Metser, Ur, Roshini Kulanthaivelu, Julia Duder, Ricarda Hinzpeter, Simron Singh, Rebecca Wong, Sten Myrehaug, Daryl Gray, Patrick Veit-Haibach, Amit Singnurkar,
and et al. 2025. "68Ga-DOTATATE PET/CT in the Initial Staging of Well-Differentiated Gastroenteropancreatic and Non-Gastroenteropancreatic Neuroendocrine Tumors: Results of a Prospective Registry" Cancers 17, no. 3: 434.
https://doi.org/10.3390/cancers17030434
APA Style
Metser, U., Kulanthaivelu, R., Duder, J., Hinzpeter, R., Singh, S., Wong, R., Myrehaug, S., Gray, D., Veit-Haibach, P., Singnurkar, A., Li, X., & Ezzat, S.
(2025). 68Ga-DOTATATE PET/CT in the Initial Staging of Well-Differentiated Gastroenteropancreatic and Non-Gastroenteropancreatic Neuroendocrine Tumors: Results of a Prospective Registry. Cancers, 17(3), 434.
https://doi.org/10.3390/cancers17030434
